The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rowalief 500 mg Film-coated tablets

Rowa Pharmaceuticals LimitedPA0074/065/001

Main Information

Trade NameRowalief 500 mg Film-coated tablets
Active SubstancesParacetamol
Dosage FormFilm-coated tablet
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/065/001

Group Information

ATC CodeN02BE Anilides
N02BE01 paracetamol


License statusAuthorised
Licence Issued14/12/2012
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of LicenceGeneral Sale: MAXIMUM PACK SIZE 12. Contains only paracetamol as analgesic. Maximum one pack per sale. Pharmacy only: MAXIMUM PACK SIZE 24. Maximum two packs per sale. Prescription only: Pack size greater than 24. Product not supplied in blister packs. Promotion to Public: Pack size not more than 24 Promotion to Healthcare professionals: Pack size greater than 24
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back